148 related articles for article (PubMed ID: 27278304)
1. Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging.
Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
J Med Ultrason (2001); 2003 Sep; 30(3):141-51. PubMed ID: 27278304
[TBL] [Abstract][Full Text] [Related]
2. Assessment of image quality of contrast-enhanced power doppler imaging in hepatocellular carcinoma with the personal ultrasound imager: Comparison with the conventional machine.
Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
J Med Ultrason (2001); 2003 Mar; 30(1):31-8. PubMed ID: 27285152
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced agent detection imaging: Early experience in hepatocellular carcinoma.
Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
J Med Ultrason (2001); 2003 Jun; 30(2):77-84. PubMed ID: 27278162
[TBL] [Abstract][Full Text] [Related]
4. Value of new contrast harmonic technique for detecting tumor vascularity in hepatocellular carcinoma: Preliminary results.
Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
J Med Ultrason (2001); 2003 Jun; 30(2):85-92. PubMed ID: 27278163
[TBL] [Abstract][Full Text] [Related]
5. Advanced dynamic flow imaging with contrast-enhanced ultrasonography for the evaluation of tumor vascularity in liver tumors.
Hotta N; Tagaya T; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
Clin Imaging; 2005; 29(1):34-41. PubMed ID: 15859016
[TBL] [Abstract][Full Text] [Related]
6. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.
Choi BI; Kim TK; Han JK; Kim AY; Seong CK; Park SJ
Radiology; 2000 Feb; 214(2):381-6. PubMed ID: 10671584
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma.
Hotta N; Tagaya T; Maeno T; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
Hepatogastroenterology; 2003; 50(54):1867-71. PubMed ID: 14696421
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI.
Shima T; Mizuno M; Otsuji H; Mizuno C; Obata H; Park H; Nakajo S; Okanoue T
J Med Ultrason (2001); 2005 Sep; 32(3):107-13. PubMed ID: 27277266
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
[TBL] [Abstract][Full Text] [Related]
11. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.
Kim AY; Choi BI; Kim TK; Han JK; Yun EJ; Lee KY; Han MC
Radiology; 1998 Oct; 209(1):135-40. PubMed ID: 9769824
[TBL] [Abstract][Full Text] [Related]
13. Detection of intratumoral vascularity in small hepatocellular carcinoma by coded phase inversion harmonics.
Wen YL; Zhou P; Kudo M
Intervirology; 2004; 47(3-5):169-78. PubMed ID: 15383726
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
[TBL] [Abstract][Full Text] [Related]
15. Contrast advanced dynamic flow imaging and contrast pulse subtraction imaging: Preliminary results in hepatic tumors.
Wen YL; Kudo M; Maekawa K; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T
J Med Ultrason (2001); 2002 Dec; 29(4):195-204. PubMed ID: 27277964
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
[TBL] [Abstract][Full Text] [Related]
17. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
[TBL] [Abstract][Full Text] [Related]
18. Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound.
Koda M; Matsunaga Y; Ueki M; Maeda Y; Mimura K; Okamoto K; Hosho K; Murawaki Y
Eur Radiol; 2004 Jun; 14(6):1100-8. PubMed ID: 14676975
[TBL] [Abstract][Full Text] [Related]
19. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
[TBL] [Abstract][Full Text] [Related]
20. Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agent.
Ding H; Kudo M; Maekawa K; Suetomi Y; Minami Y; Onda H
Hepatol Res; 2001 Nov; 21(3):242-251. PubMed ID: 11673109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
